| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.049 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |